Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1996
08/20/1996US5547696 Growth hormone stabilized with valine
08/20/1996US5547683 Method for producing microgranulated particle
08/20/1996US5547682 Reticulendothelial system contrast agent for use in magnetic resonance imaging
08/20/1996US5547681 Dermal patch
08/20/1996US5547680 Sterilizing carboxypolymethylene solution having acidic ph by heating, forming aminocaproic acid by combining it with water, sterilizating by filter sterilization, combining both solutions to form gel, prevents secondary hemorrhage
08/20/1996US5547678 Mixture of kojic acid and sunscreen agent
08/20/1996US5547677 Antimicrobial oil-in-water emulsions
08/20/1996US5547671 Extracts from kudzu plant, ginseng, ginger, citrus fruits, tree barks, thiamine
08/20/1996US5547662 Preparation of a skin surface for a surgical procedure
08/20/1996US5547656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications
08/20/1996CA2090719C In vivo delivery of active factors by co-cultured cell implants
08/20/1996CA2080648C Process for producing a pharmaceutical tablet
08/20/1996CA2019324C Fosinopril tablet formulations
08/20/1996CA1338530C Means for constraining a rumen drug delivery device in a rolled configuration
08/18/1996CA2169810A1 Formulated medicines and processed foods to treat and prevent stomatitis
08/15/1996WO1996024618A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996WO1996024377A1 Medicament in particle form
08/15/1996WO1996024375A1 New oral pharmaceutical dosage form
08/15/1996WO1996024374A1 Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
08/15/1996WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996WO1996024363A1 Therapeutic methods and preparations using rubidium ions
08/15/1996WO1996024359A1 Novel pharmaceutical formulation
08/15/1996WO1996024355A1 Novel pharmaceutical combination
08/15/1996WO1996024354A1 Novel pharmaceutical composition
08/15/1996WO1996024352A1 Pridinol-containing patch
08/15/1996WO1996024342A1 Concomitant treatment with oral bismuth compounds
08/15/1996WO1996024341A1 Concomitant treatment with bismuth and antibacterials
08/15/1996WO1996024340A1 A method of preparing stable drug nanoparticles
08/15/1996WO1996024339A1 Compositions comprising nanoparticles of nsaid
08/15/1996WO1996024338A1 New pharmaceutical formulation and process
08/15/1996WO1996024337A1 ORAL DOSAGE-FORMS CONTAINING A β-LACTAM ANTIBIOTIC
08/15/1996WO1996024336A1 Nsaid nanoparticles
08/15/1996WO1996024335A1 Sugar base surfactant for nanocrystals
08/15/1996WO1996024334A1 Lipid constructs for cytoplasmic delivery of agents
08/15/1996WO1996024333A1 Lipid constructs for targeting to vascular smooth muscle tissue
08/15/1996WO1996024332A1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
08/15/1996WO1996024331A1 New medical forms with prolonged effect applied in eye medicine and the method for preparation thereof
08/15/1996WO1996024330A1 Method and device for administering analgesics
08/15/1996WO1996024325A1 Improved topical application emulsions
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996018300A3 Adherent disinfecting compositions and methods relating thereto
08/15/1996WO1996007397A3 Delivery of solid drug compositions
08/15/1996CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
08/15/1996CA2212165A1 Method and device for administering analgesics
08/15/1996CA2211464A1 Novel pharmaceutical composition
08/15/1996CA2211409A1 Novel pharmaceutical formulation
08/15/1996CA2211263A1 Improved topical application emulsions
08/15/1996CA2210664A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996CA2207304A1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
08/15/1996CA2206430A1 Sugar base surfactant for nanocrystals
08/14/1996EP0726321A2 Method for production of arachidonic acid
08/14/1996EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration
08/14/1996EP0726073A2 Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725791A1 Recombinant p53 adenovirus methods and compositions
08/14/1996EP0725789A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
08/14/1996EP0725664A1 Disposable dosage unit for iontophoresis-facilitated delivery
08/14/1996EP0725648A1 Hepatoselective pharmaceutical actives
08/14/1996EP0725645A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
08/14/1996EP0725642A1 Stabilized prostaglandin e 1?
08/14/1996EP0725640A1 Use of lobeline for the treatment of nicotine withdrawal
08/14/1996EP0725637A1 Parenteral busulfan for treatment of malignant disease
08/14/1996EP0725634A1 Plaster for the treatment of nail mycoses
08/14/1996EP0725633A1 Detection of h. pylori in the stomach
08/14/1996EP0725632A1 Controlled release osmotic infusion system
08/14/1996EP0725631A1 Novel method for preparing dry pharmaceuticals capable of virtually instantaneous disintegration, and resulting pharmaceuticals
08/14/1996EP0725630A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
08/14/1996EP0725629A1 Liposomal defensins
08/14/1996EP0725628A1 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
08/14/1996EP0725627A1 Orally-administered dosage form for animals, preparation method therefor and uses thereof
08/14/1996EP0725626A1 Gelatin capsule fill able to foam
08/14/1996EP0725625A1 Gelatin capsule fill able to foam
08/14/1996EP0725624A1 Improvements in and relating to carrier particles for use in dry powder inhalers
08/14/1996EP0725570A1 Composition and system for oral administration to animals
08/14/1996EP0646003B1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres
08/14/1996EP0615443B1 Immediate-effect flurbiprofen-containing medicament and its use
08/14/1996EP0474714B1 A fructose-based granulated product and a process for the production thereof
08/14/1996EP0471751B1 Antineoplastic solution and method for treating neoplasms
08/14/1996DE3390423C2 Effervescent tablets mfr.
08/14/1996DE19503993A1 Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride
08/14/1996CN1128957A Implantable drug delivery means
08/14/1996CN1128955A Percutaneously absorbable prepn.
08/14/1996CN1128954A Phosphazene polyelectrolytes as immunoadjuvants
08/14/1996CN1128953A Hydrogel microencapsulated vaccines
08/14/1996CN1128950A Method for modulating human sexual response
08/14/1996CN1128948A Pharmaceutical composition for immounomodulating and adjuvant treatment
08/14/1996CN1128947A Soft-shelled gelatin encapsulated particles
08/14/1996CN1128946A Transfusion container, transfusion prepn., and comprehensive vitamin-containing high-calorie transfusion prepn.
08/14/1996CN1128671A Cyclosporin soft capsule composition
08/14/1996CN1128670A Medicine for curing leukorrhea and prepn. method thereof
08/14/1996CN1128668A Natural medicinal health-care products-complex prescription of pearl and snake powder
08/14/1996CN1128667A Thrombus-eliminating pills
08/14/1996CN1128662A Oral liquid for curing cancer and prepn. method thereof
08/14/1996CN1128660A Medicinal ointment for resolving blood stasis
08/14/1996CN1128658A Method for application of copper salicylacetate
08/14/1996CN1128656A Application of anisodamine for prepn. of eye drops for curing pyopia
08/14/1996CN1128655A Injectable liposomal pharmaceutical prepn.
08/13/1996US5545722 Hepatocyte-growth agent
08/13/1996US5545673 Method for reducing risk of infection by sexually transmitted viruses
08/13/1996US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts